Skip to main content
FinSpry Logo
FinSpry
AMGN logo
AMGN
(NASDAQ)
Amgen Inc.
$347.94-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Amgen (AMGN) Stock Price & Financial Analysis

Amgen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$345.87 - $354.16
52-Week High$391.29
52-Week Low$261.43
Open$352.72
Volume1.60M
Average Volume (3M)1.60M
Market Cap188.93B
Shares Outstanding543.00M
P/E Ratio (TTM)24.88
Forward P/E13.20
Price to Sales (P/S)5.22
Price to Book (P/B)22.16
EV/EBITDA14.04
Revenue (TTM)36.75B
Net Income (TTM)7.71B
Free Cash Flow (TTM)8.10B
EPS (TTM)$14.20
Profit Margin20.98%
Operating Margin24.71%
Return on Equity (ROE)89.06%
Debt to Equity6.31
50-Day MA$363.06
200-Day MA$318.96
52-Week Change15.10%
Annual Dividend$9.66
Dividend Yield2.73%
Payout Ratio68.02%
Last Dividend Ex-DateMay 15, 2026

Frequently Asked Questions About Amgen

What is the current stock price for AMGN?

As of the latest trading session, AMGN stock trades at $347.94. The 52-week range is $261.43–$391.29, with a day range of $345.87–$354.16.

What is the P/E ratio for AMGN?

Amgen's trailing P/E ratio is 24.9, meaning investors pay $24.9 for every $1 of annual earnings. The forward P/E is 13.2, reflecting analyst expectations for future earnings. Amgen operates in the Healthcare sector.

Does AMGN pay dividends?

Yes, Amgen pays a 2.73% annual dividend yield ($9.66 per share). The payout ratio is 68.0%. The last ex-dividend date was 2026-05-15.

What do analysts recommend for AMGN?

Based on 31 analysts, the consensus for AMGN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of AMGN?

Amgen's market capitalization is $188.93B, classifying it as a large-cap company. Amgen operates in the Healthcare sector within the Drug Manufacturers - General industry.